Parameters | Range | Day 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
---|---|---|---|---|---|---|---|---|
 | Group |  | (Mean ± SD) |  |  |  |  |  |
White blood count | Â | Â | Â | Â | Â | Â | Â | |
 | Placebo + Tamoxifen | 4-11 | 6.29 ± 2.09 | 6.77 ± 1.79 | 7.06 ± 2.07 | 7.11 ± 2.37 | 7.22 ± 7.22 | 7.36 ± 7.36 |
 | TRF + Tamoxifen | (×109/L) | 5.86 ± 2.01 | 5.81 ± 1.59 | 5.86 ± 1.78 | 6.28 ± 1.92 | 6.33 ± 1.76 | 6.46 ± 1.62 |
Red blood count | Â | Â | Â | Â | Â | Â | Â | |
 | Placebo + Tamoxifen | 3.8-5.8 | 4.48 ± 0.48 | 4.46 ± 0.44 | 4.41 ± 0.40 | 4.49 ± 0.46 | 4.43 ± 0.54 | 4.55 ± 0.53 |
 | TRF + Tamoxifen | (×1012/L) | 3.95 ± 0.81 | 4.24 ± 0.41 | 4.27 ± 0.34 | 4.28 ± 0.34 | 4.27 ± 0.45 | 4.28 ± 0.40 |
Hemoglobin | Â | Â | Â | Â | Â | Â | Â | |
 | Placebo + Tamoxifen | 11.5-16.5 | 12.49 ± 1.28 | 12.40 ± 1.18 | 12.63 ± 1.16 | 12.66 ± 0.96 | 12.61 ± 0.92 | 12.70 ± 0.96 |
 | TRF + Tamoxifen | (g/dl) | 11.79 ± 2.48 | 12.71 ± 1.13 | 12.67 ± 0.93 | 12.72 ± 0.99 | 12.65 ± 1.27 | 12.77 ± 1.01 |
Hematocrit | Â | Â | Â | Â | Â | Â | Â | |
 | Placebo + Tamoxifen | 37-47 | 38.90 ± 3.27 | 38.34 ± 2.56 | 38.53 ± 2.82 | 38.48 ± 2.68 | 37.44 ± 8.69 | 38.69 ± 3.06 |
 | TRF + Tamoxifen | (%) | 35.51 ± 7.30 | 38.76 ± 4.31 | 37.96 ± 4.32 | 38.68 ± 2.97 | 38.36 ± 4.19 | 38.63 ± 3.27 |
Lymphocyte | Â | Â | Â | Â | Â | Â | Â | |
 | Placebo + Tamoxifen | 20-45 | 33.03 ± 6.62 | 33.37 ± 6.21 | 34.30 ± 8.13 | 35.19 ± 6.27 | 34.82 ± 8.32 | 35.48 ± 7.20 |
 | TRF + Tamoxifen | (%) | 31.42 ± 8.35 | 33.79 ± 9.41 | 33.22 ± 8.58 | 34.65 ± 8.68 | 34.59 ± 6.63 | 36.39 ± 9.58 |
Platelet count | Â | Â | Â | Â | Â | Â | Â | |
 | Placebo + Tamoxifen | 150-400 | 221.52 ± 60.59 | 221.48 ± 46.09 | 222.19 ± 61.39 | 238.10 ± 61.63 | 250.00 ± 61.87 | 260.10 ± 57.85 |
 | TRF + Tamoxifen | (×109/L) | 221.16 ± 89.81 | 217.89 ± 50.74 | 217.63 ± 58.52 | 226.13 ± 49.69 | 247.74 ± 76.05 | 243.07 ± 61.02 |